Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05133284
Other study ID # RECHMPL21_0634
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 1, 2021
Est. completion date March 25, 2022

Study information

Verified date October 2021
Source University Hospital, Montpellier
Contact Amaria BAGHDADLI, PU-PH
Phone 04 67 33 63 83
Email a-baghdadli@chu-montpellier.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by attention deficit, impulsivity and hyperactivity. It's one of the most frequently encoutered disorder in child psychiatry. ADHD has a significant impact on the quality of life of children and their parents. In the child psychiatry department of the MPEA Peyre Plantade, a Therapeutic Education program specific to ADHD has been set up for children and their parents. This program consists of different workshops whose aim is to reduce the ADHD repercussions on the daily life of children and their families and thus improve their quality of life. The principal aim of our study is to evaluate the effectiveness of this program in improving the quality of life of children with ADHD and their parents.


Recruitment information / eligibility

Status Recruiting
Enrollment 24
Est. completion date March 25, 2022
Est. primary completion date March 1, 2022
Accepts healthy volunteers No
Gender All
Age group 8 Years to 13 Years
Eligibility Inclusion criteria: - Aged 8 to 13 - With a diagnosis of ADHD - Living in the herault department - Participatinf in the therapeutic education program " Living Well with ADHD " Exclusion criteria: - Parent's objection to the use of data collected - Parent unable to complete questionnaires

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Uh Montpellier Montpellier

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Other Quality of life of parents To evaluate the effectiveness of the program in improving the overall quality of life of parents measured by the WHOQOL-BREF questionnaire (Total score & sub score) day 1
Other Clinical and sociodemiographic characteristics To Identify Clinical and sociodemographic characteristics that influence the quality of life of children and parents day 1
Primary Quality of life of children To Evaluate the effectiveness of the therapeutic education program "Living better with ADHD" in improving quality of life of children with ADHD measured by the Kidscreen 27 questionnaire (Total score & sub score) 1 day
See also
  Status Clinical Trial Phase
Completed NCT01883817 - Effect of Omega-3 Fatty Acid on Cortical Function in ADHD Phase 3
Completed NCT03662763 - Extended-release Guanfacine Hydrochloride in Children/Adolescents With Attention-deficit/Hyperactivity Phase 3
Recruiting NCT01154686 - Working Memory Training in College Students With Attention-Deficit Hyperactivity Disorder/Learning Disabilities N/A
Unknown status NCT01130467 - Event-related Potentials in Management of Children With Attention-deficit/Hyperactivity Disorder Phase 4
Completed NCT04577417 - Stimulant Medication Effects on Auditory Sensitivity in Teens With ADHD
Completed NCT03948607 - Neural Mechanisms of Attention Lapses in Adult ADHD
Completed NCT06064942 - Multiple Family Narrative Therapy for Chinese Families of Children With Attention Deficit Hyperactivity Disorder N/A
Completed NCT06030024 - Efficacy of Repetitive Transcranial Magnetic Stimulation in Adult Attention Deficit Disorder N/A
Completed NCT05096975 - Personality Profile of Children and Adolescents With ADHD and With or Without Emotional Dysregulation
Completed NCT03852966 - Better Sleep in Psychiatric Care - ADHD Pilot Study N/A
Terminated NCT01730079 - Near Infrared Spectroscopy in Children With Autism and ADHD
Completed NCT02062411 - A Randomized Controlled Study of Cognitive Behavioral Therapy for Adults With Attention Deficit Disorder N/A
Completed NCT01000064 - Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits Phase 3
Completed NCT00048360 - Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults Phase 3
Completed NCT00776737 - Studies of Measures of Attention N/A
Recruiting NCT05243186 - Assessing Cognitive Performance Among Adults With Attention Disorders Working on Treadmill Phase 2/Phase 3
Completed NCT02635035 - Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT Phase 2
Completed NCT01369459 - Medication Integration in Treatment of Comorbid Adolescent Substance Users/Attention Deficit Hyperactivity Disorder Phase 1
Recruiting NCT05406414 - The Efficacy of a Transdiagnostic Sleep and Circadian Intervention for Patients With Mental Disorders and Sleep Problems N/A
Not yet recruiting NCT06248229 - A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD). Phase 4